Malignancy in chronic liver disease.
作者信息
Czaja A J, Summerskill W H
出版信息
Gastroenterology. 1977 Jul;73(1):192-3.
PMID:863193
Abstract
摘要
相似文献
1
Malignancy in chronic liver disease.慢性肝病中的恶性肿瘤。
Gastroenterology. 1977 Jul;73(1):192-3.
2
3
[Prognosis of chronic hepatitis].
Acta Gastroenterol Latinoam. 1980;10(1):35-48.
4
Treatment of chronic active hepatitis. An analysis of three controlled trials.
Gastroenterology. 1977 Dec;73(6):1422-30.
5
Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared.泼尼松用于慢性活动性肝病：剂量滴定、标准剂量及与硫唑嘌呤联合使用的比较
Gut. 1975 Nov;16(11):876-83. doi: 10.1136/gut.16.11.876.
6
Circulating thyroxine in chronic active liver disease.慢性活动性肝病中的循环甲状腺素
Isr J Med Sci. 1974 Nov;10(11):1405-14.
7
[Long-term therapy of chronic hepatitis].
Dtsch Z Verdau Stoffwechselkr. 1970;30(1):15-7.
8
Carcinoma of the cervix after treatment with prednisone and azathioprine for chronic active hepatitis.用泼尼松和硫唑嘌呤治疗慢性活动性肝炎后发生的宫颈癌。
Am J Gastroenterol. 1978 Oct;70(4):383-4.
9
[Treatment of primary chronic glomerulonephritis with a triple combination of prednisone, azathioprine and a nitrogen mustard derivative].
Rev Clin Esp. 1975 May 31;137(4):321-5.
10
Letter: Prednisone and azathioprine treatment of liver disease.信函：泼尼松和硫唑嘌呤治疗肝病
Gastroenterology. 1975 May;68(5 Pt 1):1328.
引用本文的文献
1
Hepatocellular carcinoma and other malignancies in autoimmune hepatitis.自身免疫性肝炎中的肝细胞癌和其他恶性肿瘤。
Dig Dis Sci. 2013 Jun;58(6):1459-76. doi: 10.1007/s10620-012-2525-5. Epub 2013 Jan 10.
Zotero 插件